Turkish Journal of Physical Medicine and Rehabilitation 2012 , Vol 58 , Num 2
Cervix Cancer in a Patient With Ankylosing Spondylitis Using Etanercept: A Case Report
Pınar Doruk 1 ,Mehmet Adam 1 ,Berrin Leblebici 1
1 Başkent Üniversitesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Adana Uygulama ve Araştırma Merkezi, Adana, Türkiye DOI : 10.4274/tftr.60024

Tumor necrosis factor-alpha inhibitors (anti TNF-alpha) are agents that increasingly used in the treatment of ankylosing spondylitis resistant to classical disease-modifying treatment and they provide better functional outcome. However, these agents have serious side effects. Their safety has been questioned by several published reports of increased risk for malignancies. In this study, we present a patient with ankylosing spondylitis who developed cervix cancer after receiving anti TNF-alpha therapy for 19 months. 

Keywords : Ankylosing spondylitis, etanercept, cervix cancer